Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $28 to $29.
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $23 to $28.
B. Riley Securities analyst Josh Nichols maintains Gentex (NASDAQ:GNTX) with a Buy and raises the price target from $28 to $32.
Baird analyst David Leiker maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $26 to $30.
Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in Friday's midday tradin...
Gentex shares jumped 15% after beating Q2 estimates, boosting full-year sales guidance, and posting strong margins despite weak...
